[Assessment and management of aortic stenosis].

Rev Med Suisse

Service de cardiologie, Département de médecine, CHU Sart-Tilman, Liège, Belgique.

Published: August 2011

Surgical aortic valve replacement is the sole validated treatment of aortic stenosis. The indications for surgery rely on risk/benefit ratio and on the official recommendations. A symptomatic patient with severe aortic stenosis should be submitted to surgery. The indication of valve replacement is more difficult in asymptomatic patients. The decision should integrate a combination of an exercise test and prognostic parameters associated with poor outcome. Most of them are obtained by Doppler echocardiography. Patients presenting with severe aortic stenosis and low transvalvular gradient constitute a subgroup of patients who require appropriate echocardiographic assessment to determine the potential benefit and risk of surgery. Transluminal aortic valve implantation is a new modality for patients at high surgical risk.

Download full-text PDF

Source

Publication Analysis

Top Keywords

aortic stenosis
12
aortic valve
8
valve replacement
8
severe aortic
8
aortic
6
[assessment management
4
management aortic
4
aortic stenosis]
4
stenosis] surgical
4
surgical aortic
4

Similar Publications

Background: Triglyceride-glucose-BMI (TyG-BMI) index is a surrogate marker of insulin resistance and an important predictor of cardiovascular disease. However, the predictive value of TyG-BMI index in the progression of non-severe aortic stenosis (AS) is still unclear.

Methods: The present retrospective observational study was conducted using patient data from Aortic valve diseases RISk facTOr assessmenT andprognosis modeL construction (ARISTOTLE).

View Article and Find Full Text PDF

Background: The optimal timing for percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve replacement (TAVR) is debatable.

Objectives: The aim of this study was to compare outcomes based on the timing of PCI in stable coronary artery disease patients undergoing TAVR.

Methods: Leveraging the STS/ACC TVT Registry and Medicare Linkage, we analyzed patients with stable coronary artery disease undergoing PCI and TAVR between 2015 and 2023 using the SAPIEN 3 balloon-expandable valve platform.

View Article and Find Full Text PDF

Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.

JACC Cardiovasc Interv

January 2025

Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, Ramsay-Santé, Massy, France. Electronic address:

Background: The prevalence of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is high. Treatment of a coronary events (CE) after TAVR can be technically challenging.

Objectives: The authors sought to assess the incidence and prognostic impact of CE after TAVR.

View Article and Find Full Text PDF

Age-stratified Surgical Aortic Valve Replacement for Aortic Stenosis: What Does It Mean for Patients with Bicuspid Aortic Valve Disease?

J Cardiothorac Vasc Anesth

January 2025

Division of Congenital Cardiac Anesthesiology, University of Alabama at Birmingham School of Medicine, Birmingham, AL; Bruno Pediatric Heart Center, Children's of Alabama, Birmingham, AL. Electronic address:

View Article and Find Full Text PDF

See, Touch, Feel: The Need for Modern PCI in TAVR Patients.

JACC Cardiovasc Interv

January 2025

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Cardio Center, IRCCS Humanitas Research Hospital, Rozzano, Italy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!